VISHEE(SH:688580) Sou Hu Cai Jing·2025-08-27 23:56Core Insights - Weisi Medical (688580.SH) reported a total revenue of 210 million yuan for the first half of 2025, ranking 72nd among disclosed peers [1] - The company's net profit attributable to shareholders was 69.32 million yuan, with a net cash inflow from operating activities of 64.78 million yuan [1] - The latest debt-to-asset ratio is 8.95%, an increase of 0.48 percentage points from the previous quarter [1] - The gross profit margin decreased to 66.09%, down by 0.56 percentage points from the previous quarter [1] - Return on equity (ROE) stands at 4.28% [1] - The diluted earnings per share (EPS) is 0.72 yuan [1] - Total asset turnover ratio is 0.12 times, ranking 76th among disclosed peers, while inventory turnover ratio is 1.78 times [1] - The number of shareholders is 8,095, with the top ten shareholders holding 66.20 million shares, accounting for 69.13% of the total share capital [1] Shareholding Structure - The largest shareholder is Wang Zhiyu, holding 39.41% of shares [1] - The second-largest shareholder is Hu Ping, with a 16.4% stake [1] - Other notable shareholders include Nanjing Zhida Venture Capital Center (Limited Partnership) at 8.29%, and Shenzhen Yanghe Biomedical Industry Investment Co., Ltd. at 1.80% [1]